141 related articles for article (PubMed ID: 35577181)
1. Tailoring therapeutic effect for chronotherapy of variant angina based on pharmacodynamic/deconvolution integrated model method.
Li Z; Li Z; Yu H; Wang B; Song W; Liu J
Eur J Pharm Sci; 2022 Aug; 175():106208. PubMed ID: 35577181
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA - loaded pellets developed for angina chronotherapy: Deconvolution-based formulation design and optimization, pharmacokinetic and pharmacodynamic evaluation.
Yan HX; Li J; Li ZH; Zhang WL; Liu JP
Eur J Pharm Sci; 2015 Aug; 76():156-64. PubMed ID: 25976225
[TBL] [Abstract][Full Text] [Related]
3. Development of cryptotanshinone-loaded pellets for angina chronotherapy:
Li Z; Zhang S; Yan H; Liu J
Asian J Pharm Sci; 2018 Jul; 13(4):310-316. PubMed ID: 32104404
[TBL] [Abstract][Full Text] [Related]
4. Development of protocatechualdehyde proliposomes-based sustained-release pellets with improved bioavailability and desired pharmacokinetic behavior for angina chronotherapy.
Zhang S; Yan H; Yu P; Xia Y; Zhang W; Liu J
Eur J Pharm Sci; 2016 Oct; 93():341-50. PubMed ID: 27568854
[TBL] [Abstract][Full Text] [Related]
5. Influence of release rate, dose and co-administration on pharmacokinetics, pharmacodynamics and PK-PD relationship of tanshinone IIA and tanshinol.
Li Z; Li Z; Wang B; Liu J
Eur J Pharm Sci; 2022 Jan; 168():106042. PubMed ID: 34656775
[TBL] [Abstract][Full Text] [Related]
6. Tanshinol sustained-release pellets with absorption enhancer: optimization, characterization, pharmacokinetics and pharmacodynamics.
Yu P; Zhang S; Zhang W; Yang J; Lu J; Liu J
Drug Dev Ind Pharm; 2017 Jul; 43(7):1093-1102. PubMed ID: 28165803
[TBL] [Abstract][Full Text] [Related]
7. Development of sustained-release pellets to modulate the in vivo processes of the main active components of Danshen: A pharmacokinetic and pharmacodynamic evaluation.
Wang D; Zhang S; Tang H; Jiang C; Wang B; Liu J
Phytomedicine; 2019 May; 58():152793. PubMed ID: 31005724
[TBL] [Abstract][Full Text] [Related]
8. Clinical benefits versus shortcomings of diltiazem once-daily in the chronotherapy of cardiovascular diseases.
Ezeugo U; Glasser SP
Expert Opin Pharmacother; 2009 Feb; 10(3):485-91. PubMed ID: 19191683
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pharmacokinetic and pharmacodynamic relationship for oral sustained-release atenolol pellets in rats.
Jia J; Dong C; Zhang W; Cui Y; Liu J
J Pharm Biomed Anal; 2011 May; 55(2):342-8. PubMed ID: 21353427
[TBL] [Abstract][Full Text] [Related]
10. Optimizing delivery systems to tailor pharmacotherapy to cardiovascular circadian events.
Carter BL
Am J Health Syst Pharm; 1998 Nov; 55 Suppl 3():S17-23. PubMed ID: 9825045
[TBL] [Abstract][Full Text] [Related]
11. Design and optimization of colon-targeted system of theophylline for chronotherapy of nocturnal asthma.
Patel MM; Amin AF
J Pharm Sci; 2011 May; 100(5):1760-72. PubMed ID: 21154966
[TBL] [Abstract][Full Text] [Related]
12. Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
Waller DG
J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S21-7; discussion S29-31. PubMed ID: 10499557
[TBL] [Abstract][Full Text] [Related]
13. Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease.
Smolensky MH; Portaluppi F
Am Heart J; 1999 Apr; 137(4 Pt 2):S14-S24. PubMed ID: 10097242
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
Sica D; Frishman WH; Manowitz N
Heart Dis; 2003; 5(3):176-81. PubMed ID: 12783630
[TBL] [Abstract][Full Text] [Related]
15. Covera-HS offers proven protection in hypertension and angina in alignment with circadian rhythm.
Adv Nurse Pract; 1997 Aug; 5(8):66. PubMed ID: 9459960
[No Abstract] [Full Text] [Related]
16. Long-acting diltiazem HCl for the chronotherapeutic treatment of hypertension and chronic stable angina pectoris.
Claas SA; Glasser SP
Expert Opin Pharmacother; 2005 May; 6(5):765-76. PubMed ID: 15934903
[TBL] [Abstract][Full Text] [Related]
17. Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia.
Glasser SP; Frishman W; White WB; Stone P; Johnson MF
Clin Cardiol; 2000 Jul; 23(7):524-9. PubMed ID: 10894441
[TBL] [Abstract][Full Text] [Related]
18. Biorhythms and chronotherapy in cardiovascular disease.
Cooke HM; Lynch A
Am J Hosp Pharm; 1994 Oct; 51(20):2569-80. PubMed ID: 7847420
[TBL] [Abstract][Full Text] [Related]
19. [Application of chronotherapy to cardiovascular diseases].
Conte G; Rigon N; Perrone A
Recenti Prog Med; 1998 Sep; 89(9):465-9. PubMed ID: 9796379
[TBL] [Abstract][Full Text] [Related]
20. Circadian variation of basal total vascular tone and chronotherapy in patients with vasospastic angina pectoris.
Mori H; Nakamura N; Tamura N; Sawai M; Tanno T; Narita T; Singh RB; Otsuka K
Biomed Pharmacother; 2002; 56 Suppl 2():339s-344s. PubMed ID: 12653190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
